Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
5.08
-0.01 (-0.20%)
Aug 6, 2026, 12:47 PM EDT - Market open

Vanda Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
55.8884.85102.32135.82135.0352.07
Short-Term Investments
114.15179272.33252.44331.83380.74
Cash & Short-Term Investments
170.03263.85374.64388.26466.86432.81
Cash Growth
-47.77%-29.57%-3.51%-16.84%7.87%17.70%
Accounts Receivable
59.6954.5847.134.1633.5132.47
Inventory
1.681.851.731.361.191.03
Other Current Assets
33.0926.9915.429.1717.7312
Total Current Assets
264.48347.26438.89432.95519.29478.3
Net Property, Plant & Equipment
23.9513.5112.689.1410.9712.39
Other Intangible Assets
113.12117.09114.1121.3718.5720.08
Other Long-Term Assets
10.9211.0890.5484.9985.4283.03
Total Assets
412.47488.95656.2648.44634.25593.79
Accounts Payable
69.9968.339.0938.4645.5534.44
Other Current Liabilities
94.0376.8760.949.2445.8939.98
Total Current Liabilities
164.03145.1699.9887.791.4474.42
Long-Term Leases
18.27.078.097.018.8110.06
Other Long-Term Liabilities
10.059.539.598.836.84.39
Total Long-Term Liabilities
28.2616.617.6815.8315.6114.45
Total Liabilities
192.28161.76117.66103.53107.0588.86
Common Stock
0.060.060.060.060.060.06
Additional Paid-in Capital
725.93721.26712.71700.27686.24669.22
Accumulated Other Comprehensive Income
0.040.630.07-0.03-1.19-0.18
Retained Earnings
-505.85-394.77-174.29-155.39-157.9-164.18
Shareholders' Equity
220.19327.19538.55544.91527.2504.93
Total Liabilities & Equity
412.47488.95656.2648.44634.25593.79
Total Debt
18.27.078.097.018.8110.06
Net Cash (Debt)
151.83256.78366.55381.26458.05422.76
Net Cash Growth
-52.34%-29.95%-3.86%-16.76%8.35%18.67%
Net Cash Per Share
2.554.366.306.628.047.43
Book Value
220.19327.19538.55544.91527.2504.93
Book Value Per Share
3.705.559.269.479.258.87
Tangible Book Value
107.07210.1424.45423.54508.63484.85
Tangible Book Value Per Share
1.803.577.307.368.938.52
SEC Filings: 10-K · 10-Q